Correlation Between Loncar Cancer and Principal

Can any of the company-specific risk be diversified away by investing in both Loncar Cancer and Principal at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Loncar Cancer and Principal into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Loncar Cancer Immunotherapy and Principal, you can compare the effects of market volatilities on Loncar Cancer and Principal and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Loncar Cancer with a short position of Principal. Check out your portfolio center. Please also check ongoing floating volatility patterns of Loncar Cancer and Principal.

Diversification Opportunities for Loncar Cancer and Principal

0.0

Correlation Coefficient

Loncar Cancer  Principal

Pay attention - limited upside

The 3 months correlation between Loncar and Principal is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Loncar Cancer Immunotherapy and Principal in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Principal and Loncar Cancer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Loncar Cancer Immunotherapy are associated (or correlated) with Principal. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Principal has no effect on the direction of Loncar Cancer i.e., Loncar Cancer and Principal go up and down completely randomly.

Pair Corralation between Loncar Cancer and Principal

If you would invest (100.00) in Principal on December 29, 2024 and sell it today you would earn a total of  100.00  from holding Principal or generate -100.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.0%
Values	Daily Returns

Loncar Cancer Immunotherapy  vs.  Principal

Loncar Cancer Immuno

Risk-Adjusted Performance

Very Weak

Over the last 90 days Loncar Cancer Immunotherapy has generated negative risk-adjusted returns adding no value to investors with long positions. Even with unsteady performance in the last few months, the Etf's fundamental indicators remain relatively invariable which may send shares a bit higher in April 2025. The latest agitation may also be a sign of long-running up-swing for the ETF retail investors.

Principal

Risk-Adjusted Performance

Very Weak

Over the last 90 days Principal has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, Principal is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.

Pair Trading with Loncar Cancer and Principal

The main advantage of trading using opposite Loncar Cancer and Principal positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Loncar Cancer position performs unexpectedly, Principal can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Principal will offset losses from the drop in Principal's long position.

The idea behind Loncar Cancer Immunotherapy and Principal pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.